Stephen V Liu, Director of Thoracic Oncology, Head of Developmental Therapeutics and Associate Professor at the Georgetown Lombardi Comprehensive Cancer Center, posted on X:
“Still struck by the impact our microbiome has on efficacy (and toxicity) of immunotherapy in lung cancer. Listen to this episode of the IASLC
podcast, Lung Cancer Considered, where I discuss the data with Drs. Arielle Elkrief and Bertrand Routy.”